A Retrospective, Medical Record Study to Investigate the Current Situation of Biopsy Testing in the Swedish Inoperable Non Small Cell Lung Cancer Patient Population
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Non Small Cell Lung Cancer
Both
Non Small Cell Lung Cancer
Trial Information
A Retrospective, Medical Record Study to Investigate the Current Situation of Biopsy Testing in the Swedish Inoperable Non Small Cell Lung Cancer Patient Population
Inclusion Criteria:
- Diagnosis code C34 (ICD-10).
- Inoperable lung cancer.
- Diagnosis of lung cancer made between 2010-05-31 and 2009-06-01.
Exclusion Criteria:
- Diagnosis code C34.9b.
- Diagnosis code C34.9h.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Describe complications connected to biopsy and bronchoscopy in the investigated lung cancer population.
Outcome Time Frame:
Data will be collected retrospectively from medical records. Data of complications will be collected from when the complication occurred and then any overnight stay caused by complication, approximately a few days.
Safety Issue:
No
Principal Investigator
Dr Pål Falck, PhD
Investigator Role:
Study Director
Investigator Affiliation:
AstraZeneca
Authority:
Sweden: Regional Ethical Review Board
Study ID:
NIS-OSE-DUM-2010/1
NCT ID:
NCT01139619
Start Date:
October 2010
Completion Date:
January 2013
Related Keywords:
- Non Small Cell Lung Cancer
- Biopsy Mapping
- Non small cell lung cancer
- NSCLC
- Lung cancer diagnosis
- Retrospective
- Inoperable Non Small Cell Lung Cancer
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
